Опыт включения Гамавита и Фоспренила в схему терапии гемоплазмоза кошек для повышения эффективности коррекции анемии — ретроспективный анализ

В настоящее исследование включены клинические данные, собранные с 2016 по 2023 год. Всего гемоплазмоз был выявлен у 102 особей (63 кошки и 39 котов) в возрасте от 5 месяцев до 8 лет. Из них было 34 пациента с тяжелой формой заболевания, и 68 — с легкой. У кошек с тяжелой формой гемоплазмоза в 45 % случаев болезнь осложнялась хронической почечной недостаточностью. Также 5 % из них были хроническими носителями токсоплазм. Большинство животных было из приютов или бездомными.
Одним из ведущих клинических признаков гемоплазмоза служит анемия, развивающаяся в результате массового гемолиза пораженных эритроцитов.
Цель настоящей работы состояла в том, чтобы устранить анемию и ускорить нормализацию кроветворения у кошек с гемоплазмозом. При лечении 45 животных (контрольная группа) использовали стандартную схему терапии, включавшую в себя антибиотики и глюкокортикоиды, тогда как в схему лечения 57 особей (опытная группа) добавляли гамавит и фоспренил. При использовании такой терапевтической схемы отмечали раннее купирование анемии, стимуляцию эритропоэза, восстановление формулы крови и нормализацию печеночной функции, а выздоровление больных животных наступало быстрее на 4…5 дней.

Ключевые слова: гемоплазмоз, анемия, Гамавит, Фоспренил, гемотропные микоплазмы, кошки

Supplementation of feline hemoplasmosis treatment protocol with Gamavit and Phosprenyl increases the effectiveness of anemia correction: a retrospective analysis

S.L. Savoyskaya^1,2, PhD in Vet Sc, senior research scientist, Laboratory of Cellular Immunity
¹ National Research Centre for Epidemiology and Microbiology named after the honorary academician N.F. Gamaleya of the Ministry of Health of the Russian Federation, Moscow, Russian Federation (ul. Gamaleya, 18, Moscow, RF, 123098).
² Hatiko Veterinary Clinic (h. 70, build. 1 ul. Aviacionnaya, Moscow, RF, 123182).

This study includes clinical data collected from 2016 to 2023. In total, hemoplasmosis was detected in 102 cats (63 females and 39 males) aged from 5 months to 8 years. Of these, 34 cats were diagnosed with a severe form of the disease, and 68 with a mild one. In cats with severe hemoplasmosis, in 45 % of cases, the disease was complicated by chronic renal failure. Also, 5 % of them were chronic carriers of toxoplasmas. Most of the animals were taken from shelters, or were homeless.
One of the leading clinical signs of hemoplasmosis is anemia, which develops as a result of mass hemolysis of infected red blood cells.
The aim of this work was to eliminate anemia and accelerate the normalization of hematopoiesis in cats with hemoplasmosis. For the treatment of 45 animals (control group), a standard therapy regimen was used, which included antibiotics and glucocorticoids, whereas for therapy regimen of remaining 57 cats (experimental group) Gamavit and Phosprenyl were added. Using this therapeutic scheme, early relief of anemia, stimulation of erythropoiesis, restoration of blood formula and normalization of liver function were noted as well as acceleration of clinical recovery of sick animals which occurred faster by 4…5 days.

Keywords: hemoplasmosis, anemia, Gamavit, Phosprenyl, hemotropic mycoplasmas, cats

References

1. Agafonova A.D., Sosnovskaya O.Yu.. Privalenko P.I., Grishin V.V. Profilaktika zhelezodefitsitnoy anemii u porosyat s pomoshchyu gamavita [Prevention of iron deficiency anemia in piglets with the help of gamavit], Svinovodstvo, 2021, No. 1, pp. 47-49.

2. Annikov V.V., Annikova L.V., Koldyayeva M.A., Platitsyna E.S., Otsenka terapevticheskoy effektivnosti gamavita v sostave kompleksnoy terapii pri lechenii koshek na vtoroy azotemicheskoy stadii khronicheskoy pochechnoy nedostatochnosti [Evaluation of the therapeutic efficacy of gamavit as part of complex therapy in the treatment of cats at the second azotemic stage of chronic renal failure], Trudy Vserossiyskogo NII eksperimentalnoy veterinarii im. Ya.R .Kovalenko, 2018, Vol. 80, No. 2, pp. 14-17.

3. Annikov V.V., Annikova L.V., Sanin A.V., Narovlyanskiy A.N., Pronin A.V., Sanina A.A., Korrektsiya gomeostaza pri terapii bolnykh gemoplazmozom koshek [Correction of homeostasis in the treatment of patients with hemoplasmosis of cats], Proceeding of International conference «Aktualnyye problemy veterinarnoy meditsiny. pishchevykh i biotekhnologiy», Saratov, 2018, pp. 20-23.

4. Leonard R.A., Vliyaniye gamavita. fosprenila i maksidina na ryad biokhimicheskikh pokazateley krovi sobak. bolnykh piroplazmozom [The effect of gamavit, fosprenil and maxidine on a number of biochemical parameters of the blood of dogs with piroplasmosis}, Veterinarnaya klinika, 2006, No. 3, pp. 2-5.

5. Leonard R.A., Zaripova T.E., Balakhonov A.N., Vdovina N.Yu., Narovlyanskiy A.N., Pronin A.V., Sanin A.V., Otsenka effektivnosti preparata Gamavit pri korrektsii renalnoy anemii u koshek s KhBP: kontroliruyemoye randomizirovannoye issledovaniye [Evaluation of the effectiveness of Gamavit in the correction of renal anemia in cats with CKD: a controlled randomized trial], Rossiyskiy veterinarnyy zhurnal, 2020, No. 5, pp. 8-20. DOI: 10.32416/2500-4379-2020-5-8-20.

6. Liberman E.L., Georgiu Kh., Belimenko V.V., Opyt primeneniya gamavita pri lechenii kroveparazitarnykh bolezney severnykh oleney [The experience of using gamavit in the treatment of blood parasitic diseases of reindeer, Rossiyskiy veterinarnyy zhurnal. Selskokhozyaystvennyye zhivotnyye, 2014, № 4, pp. 31-33.]

7. Pereslegina I.O., Dubrovina T.S., Klintsova T.Yu., Zotova S.N., Kozhevnikova T.N., Sanin A.V., Klinicheskiye sluchai khronicheskogo otravleniya koshek: opyt primeneniya preparata Gamavit [Clinical cases of chronic poisoning of cats: the experience of using the drug Gamavit], Veterinariya Kubani, 2017, No. 5, pp. 23-26.

8. Pereslegina I.O., Sanin A.V., Pronin A.V., Narovlyanskiy A.N., Sanina A.A., Effektivnost Gamavita pri lechenii gemobartonelleza (gemoplazmoza) koshek [The effectiveness of Gamavit in the treatment of hemobartonellosis (hemoplasmosis) of cats], Veterinariya, 2017, No.1, pp. 15-18.

9. Pereslegina I.O., Dubrovina T.S., Klintsova T.Yu., Agafonova A.D., Zotova S.N., Gamavit i fosprenil povyshayut effektivnost terapii bytovykh otravleniy koshek [Gamavit and fosprenil increase the effectiveness of therapy for domestic poisoning of cats], Veterinariya i kormleniye, 2018, No. 1, pp. 34-36.

10. Pereslegina I.O., Zhavnis S.E., Korrektsiya poliorgannoy nedostatochnosti u koshki posle toksicheskoy peredozirovki narkoza [Correction of multiple organ failure in a cat after a toxic overdose of anesthesia], Veterinariya, 2019, No. 5, pp. 46-50.

11. Pronin A.V., Narovlyansky A.N., Sanin A.V., New approaches to the prevention and treatment of viral diseases, Arch Immunol Ther Exp (Warsz), 2021 Apr 3, No. 69(1), pp. 10. DOI 10.1007/s00005-021-00613-w.

12. Savoyskaya S.L., Sanin A.V., Kozhevnikova T.N., Lecheniye sobak s anemiyey pri khronicheskoy bolezni pochek s pomoshchyu gemostimulyatora i detoksikanta [Treatment of dogs with anemia in chronic kidney disease with a hemostimulator and detoxifier], Veterinariya, 2019, No. 12, pp. 50-52.

13. Savoyskaya S.L., Agafonova A.D., Kozhevnikova T.N., Effektivnost primeneniya gamavita v sostave kompleksnoy terapii dirofilyarioza u sobak [The effectiveness of the use of gamavit as part of the complex therapy of dirofilariasis in dogs], Veterinariya i kormleniye, 2020, No. 5, p p.37-39.

14. Savoyskaya S.L., Ogorodnikova I.V., Kozhevnikova T.N., Kontrolirovaniye khronicheskoy koronavirusnoy infektsii koshek s pomoshchyu fosprenila i gamavita [Control of chronic coronavirus infection in cats with fosprenil and gamavit], Veterinariya i kormleniye, 2021, No. 3, pp. 46-48. DOI: 10.30917/ATT-VK-1814-9588-2021-3-13

15. Savoyskaya S.L., Sanina V.Yu., Kozhevnikova T.N., Ogorodnikova I.V., Povysheniye effektivnosti terapii babezioza sobak pri primenenii gamavita [Improving the effectiveness of therapy for canine babesiosis with the use of gamavit], Izvestiya Orenburgskogo agrarnogo universiteta, 2021, No. 6 (92), pp. 237-241.

16. Salichev A.V., Ozherelkov S.V., Izmestyeva A.V., Videnina A.A., Sanin A.V., Randomizirovannoye kontroliruyemoye dvoynoye slepoye issledovaniye antitoksicheskogo deystviya gamavita i gamavitforte v eksperimente in vivo s primeneniyem Imidokarba dipropionate [A randomized controlled double-blind study of the antitoxic effect of gamavit and gamavitforte in an in vivo experiment using Imidocarb dipropionate], Veterinariya Kubani, 2011, No. 6, pp.22-25.

17. Sanin. A.V., Veselovskiy V.V., Danilov L.L., Kozhevnikova T.N., Merimskaya O.S., Sosnovskaya O.Yu., Sanina V.Yu., Timofeyeva T.Yu., Usileniye mobilizatsii stvolovykh krovetvornykh kletok fosforilirovannymi poliizoprenoidami [Increased mobilization of hematopoietic stem cells by phosphorylated polyisoprenoids], Ross. immunol. zh., 2008, Vol. 2 (11), No. 2-3, pp. 113.

18. Sanin A.V., Gamavit – effektivnoye sredstvo pri ekstrakorpuskulyarnykh anemiyakh [Gamavit is an effective remedy for extracorpuscular anemia. Veterinarnaya klinika, 2009, No. 4, pp.16-19.

19. Sanin A.V., Sukhanova S.A., Proskurina O.V., Mitrokhin N.M., Ganshina I.V., Sudina G.F., Sanina V.Yu., Videnina A.A., Kozhevnikova T.N., Sanin A.A., Ozherelkov S.V., Salichev A.V., Pronin A.V., Narovlyanskiy A.N., Issledovaniye protivovospalitelnoy aktivnosti fosprenila v eksperimente [Investigation of the anti-inflammatory activity of fosprenil in an experiment], Rossiyskiy veterinarnyy zhurnal. MDZh, 2011, No. 4, pp.17-20.]

20. Sanin A.V., Kozhevnikova T.N., Sosnovskaya O.Yu., Izmestyeva A.V., Pronin A.V., Narovlyanskiy A.N., Ozherelkov S.V., Ispolzovaniye printsipov dokazatelnoy meditsiny pri issledovanii antitoksicheskogo deystviya gamavita v eksperimente in vivo [The use of the principles of evidence-based medicine in the study of the antitoxic effect of gamavit in an in vivo experiment], Veterinariya, 2015, No. 6, pp. 54-56.

21. Sanin A.V., Narovlyanskiy A.N., Pronin A.V., Kozhevnikova T.N., Agafonova A.D., Annikova L.V., Annikov V.V., Gamavit povyshayet effektivnost terapii gemobartonelleza (gemoplazmoza) u koshek: kontroliruyemoye issledovaniye [Gamavit increases the effectiveness of therapy for hemobartonellosis (hemoplasmosis) in cats: a controlled study], Rossiyskiy veterinarnyy zhurnal, 2017, No. 3, pp. 28-32.

22. Sanin A.V., Narovlyanskiy A.N., Pronin A.V., Kozhevnikova T.N., Sosnovskaya O.Yu., Zhavnis S.E., Ozherelkov S.V., Klimova D.A., Gamavit dlya korrektsii toksicheskoy gemoliticheskoy anemii i stimulyatsii eritropoeza [Gamavit for the correction of toxic hemolytic anemia and stimulation of erythropoiesis], Veterinariya, 2018, No. 10, pp. 54-59.

23. Siben A.N., Liberman E.L., Silivanova E.A., Vliyaniye immunomodulyatorov i antgelmintikov na sostoyaniye krovi severnykh oleney [The effect of immunomodulators and anthelmintics on the blood condition of reindeer], Vestnik veterinarii, 2015, No. 3 (74), pp. 64-69.

24. Barker E.N., Update on Feline Hemoplasmosis. Vet Clin North Am Small Anim Pract., 2019 Jul, No. 49(4), pp. 733-743. doi: 10.1016/j.cvsm.2019.02.009.

25. Chalhoub S., Langston C.E., Farrelly J., The Use of Darbepoetin to stimulate erythropoiesis in anemia of kidney disease in cats: 25 Cases, J. Vet. Intern. Med., 2012, No. 26(2), pp. 363-369.

26. Chikazawa S., Dunning M., A review of anaemia of inflammatory disease in dogs and cats, Journal of Small Animal Practice, 2016, No. 57(7), pp. 348-353. DOI: 10.1111/jsap.12498

27. Foley J.E., Hemotropic Mycoplasma Infections in Animals, 2023. URL: https://www.msdvetmanual.com/circulatory-system/blood-parasites/hemotropic-mycoplasma-infections-in-animals.

28. Nibblett B.M., Snead E.C., Waldner C., Taylor S.M., Jackson M.L., Knorr L.M., Anemia in cats with hemotropic mycoplasma infection: retrospective evaluation of 23 cases (1996-2005), Can Vet J., 2009 Nov, No. 50(11), pp. 1181-1185.

29. Tasker S., Hofmann-Lehmann R., Belák S., Frymus T., Addie D.D., Pennisi M.G., Boucraut-Baralon C., Egberink H., Hartmann K., Hosie M.J., Lloret A., Marsilio F., Radford A.D., Thiry E., Truyen U., Möstl K., Haemoplasmosis in cats: European guidelines from the ABCD on prevention and management, J Feline Med Surg., 2018 Mar, No. 20(3), pp. 256-261. doi: 10.1177/1098612X18758594.

30. Yamakawa A.C., Haisi A., Kmetiuk L.B., Pellizzaro M., Mendes J.C..R, Canavessi A.M.O., Ullmann L.S., de Castro W.A.C., Pessoa Araújo Júnior J., Dos Santos A.P.., Biondo A.W., Molecular detection of feline hemoplasmas and retroviruses in free-roaming and shelter cats within a university campus, JFMS Open Rep. 2023 Feb 13;9(1):20551169221148672. doi: 10.1177/20551169221148672